The signal is an ion, not a name
Mass spectrometry first turns some molecules into gas-phase ions: atomic, molecular, or radical species with a non-zero net electric charge. The instrument sorts those ions by mass-to-charge ratio, written m/z, rather than by mass alone. IUPAC defines m/z as mass number divided by charge number; that distinction matters because the same molecule carrying two charges appears at roughly half the m/z of a singly charged ion. [1]
A spectrum is a map of detected signals: m/z on the horizontal axis and detector response on the vertical axis. A peak says that ions with that measured m/z reached the detector under those conditions. Its height is a response, not a direct census of molecules; ionization efficiency, transmission, suppression by co-eluting material and instrument settings all affect intensity. [1]
From a peak to a candidate
A precisely measured m/z can constrain an elemental formula, especially when isotope patterns and charge state are considered. But it rarely identifies a unique structure. Different molecules can share a formula or even be isomers—same atoms, different connectivity or three-dimensional arrangement. In untargeted experiments, one biological molecule can also create several related features, such as isotope peaks, adducts and fragments. [2]
That is why a responsible report distinguishes a detected feature from an identified compound. Database matching can propose candidates, but a mass match alone is usually evidence for a formula or annotation, not proof of a named structure. High mass accuracy improves the search space; it does not erase chemical ambiguity. [2]
Tandem MS adds a molecular fingerprint
Tandem mass spectrometry (MS/MS) selects a precursor ion, breaks it into product ions, and measures the resulting fragment spectrum. The pattern can reveal which parts of a molecule are present or lost—much like testing how an object comes apart rather than weighing it only once. Matching experimental fragments to a spectrum measured from a reference compound is substantially stronger than matching precursor m/z alone. [2] [3]
Still, fragmentation is conditional. Collision energy, ion source, instrument design and co-isolating ions can change the pattern. Similar structures may fragment similarly, and MS/MS alone can fail to distinguish some isomers or stereoisomers. A library match is therefore a statement about agreement under stated conditions, not an eternal molecular passport. [2]
Standards and complementary tests
The strongest small-molecule identification normally compares an authentic reference standard with the unknown: precursor m/z, MS/MS fragments and chromatographic retention behavior are examined under comparable conditions. Agreement across these dimensions supports a higher-confidence identification than any one dimension alone. Spectral libraries built from measured standards are useful, but they are incomplete and platform-dependent. [2]
Orthogonal measurements can close gaps. Liquid or gas chromatography separates compounds before detection; ion mobility adds information related to shape and collision cross section; nuclear magnetic resonance or optical detectors can provide different structural clues. Combining independent properties is especially important when isomers overlap. Current best-practice guidance emphasizes explicit reporting of what was measured and how confident the annotation is. [3] [4]
Identity is not purity—and neither is biology
Identity asks, “What chemical entity is present?” Purity asks, “How much of the relevant material is present relative to impurities, contaminants or other components?” A sample can contain the correctly identified molecule and still be a complex mixture; conversely, a clean-looking dominant peak does not prove that every impurity was detected. Quantitative purity requires validated separation, calibration and controls, not just a convincing spectrum.
Biological effect is a separate question again. Detecting or identifying a molecule does not establish its dose, bioavailability, mechanism, safety or effect in a living system. MS can measure chemical signals in a sample; it cannot, by itself, turn those signals into a causal biological conclusion. The molecular identity project is therefore a chain of evidence: ion measurement, structural confirmation, impurity assessment and—only then, with appropriate experiments—biological interpretation.
TAKE THE IDEA WITH YOU
Key takeaways
- Mass spectrometry measures ions by mass-to-charge ratio and detector response; a peak is not automatically a molecular name.
- MS/MS, authentic standards and orthogonal measurements can raise identification confidence, especially for isomers and complex samples.
- Identity, purity and biological effect are different claims requiring different evidence and validation.
What this explanation cannot establish
The article is a conceptual overview, not a laboratory validation or original experiment. Exact performance depends on sample matrix, ionization mode, analyzer, resolution, chromatography, collision energy, calibration and reference-library coverage. A reference-standard match can support identity under comparable conditions but does not guarantee absence of undetected impurities. MS intensity is not automatically quantitative without calibration and controls, and chemical identification alone cannot establish biological activity, clinical effect, safety or causation.
General scientific education. Not diagnosis, treatment advice, product guidance, or evidence for any material’s suitability for human use.
References & further reading
- Definitions of terms relating to mass spectrometry (IUPAC Recommendations 2013)
Authoritative terminology for ions, m/z, spectra and detector response; the article uses its definitions of ion and mass-to-charge ratio and its warning that intensity is detector response, not ion abundance.
- Untargeted metabolomics strategies—challenges and emerging directions
Accessible peer-reviewed source explaining adducts and isotopes, the limits of MS1 formula assignment, MS/MS reference matching, incomplete libraries, instrument-dependent fragmentation and the need for orthogonal evidence.
- Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices
Peer-reviewed best-practice guide supporting chromatography plus MS/MS, reference compounds, isomer limitations, complementary NMR or optical measurements, and explicit annotation reporting.
- Identifying small molecules via high resolution mass spectrometry: communicating confidence
Peer-reviewed framework for communicating levels of confidence in small-molecule identifications rather than presenting tentative annotations as confirmed structures.
Sources accessed during preparation on 12 October 2026. Claims are bounded by each source’s methods and scope. Share a correction or a general science question through the question form.
